Patients in the Veritac-2 study were randomized to receive a standard estrogen blocker called fulvestrant, or Arvinas' ...

But a pair of treatments that launched in 2019 are already offsetting Humira's losses. Combined sales of Skyrizi, a psoriasis ...

TransDigm Group benefits from robust air travel demand and supply chain disruptions. Read why I downgrade TDG stock from buy ...

Read here for an analysis of Inter's strong financial position, growth potential, and valuation vs. peers, with potential for ...

Jon Smith talks through the scale of Nvidia stock growth over the past year but questions if further gains are going to be ...

Investors can build tremendous wealth over the long term, and it doesn't require trading in and out of hot tech stocks. If ...

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone ...

Growth stocks' performances have been more mixed in the first few weeks of 2025. However, there are still a few that could ...

Contrary to popular belief, you can strike it rich on established, high-quality companies. Today, a well-known supercharged growth stock trades at a compelling valuation due to concerns about ...

Growth ETFs can be riskier than broad-market funds, like S&P 500 ETFs. While all investments are different, there are three ...

ETF has done well in the past decade as it became one of the biggest dividend and sleep-well-at-night (SWAN) funds. It has ...

South Korea will tighten regulations on stock market listings to improve the quality and competitiveness, the financial ...